index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

56 Publications avec texte intégral

Open Access

46 %

Mots clés

Autoimmune diseases MG patients Experimental mouse models Ferrites Centres germinatifs ectopiques Etiology Immunology and Microbiology Section Transcriptome Immunity Fragile X syndromes Gd T cells Interferon type-I Exercise Age Chronic inflammation Antimir-150 Interféron de type I Myasthénie grave Thymic epithelial cells Lamin A/C nuclei Adaptive immunity Experimental autoimmune myasthenia gravis Innate immunity Interferon Germinal center Experimental models FMR1 COVID-19 Interleukin 23 Quality of life Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Cytokines Acides nucléiques endogènes Autoimmunity Interferon IFN Chemokines Myasthenia Gravis MG Maladie auto-immune Th17 cells Interferonopathy Thymus AChR antibodies Endogenous nucleic acids Acetylcholine receptor BAFF Disease susceptibility Myasthenia gravis PBMC CXCL13-CXCR5 Inflammation Chronicity Genetic associations MYB Genetics Il-23 Human myoblasts Cellules th17 LMNA Early-onset myasthenia gravis Gender Inflammatory cytokines Mass cytometry CyTOF Long-term follow-up B cells Cardiomyopathy Chemokine Conduction disease Thymoma Germinal centers Auto-immunité Acetylcholine receptor antibodies DICER CD31 CCL21 COX2 Max Acetylcholine receptors Interleukine-23 Neuromuscular junction Immunotherapy Glucocorticoids Complete Freund's adjuvant Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Follicular hyperplasia Experimental autoimmune myasthenia gravis EAMG Immune response Interferon-β Ectopic germinal centers Autoimmune disease Heart failure Interferon de type I Myoblasts Clinical cell transplantation Interferon type I Immune regulation Anticorps monoclonal Animal models M3243AG CTCF Macrophages